Abstract
Summary
The thiocyanate analog of vit. B12 (thiocyanato—cobalamin) has been shown to be fully active hematologically in pernicious anemia. In two patients the early biochemical and hematologic responses were the same as observed with same dosages of vit. B12. Further evaluation of the neurological response to this analog is necessary.
Get full access to this article
View all access options for this article.
